ACC/AHA/HFSA Focused Update
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America

https://doi.org/10.1016/j.jacc.2016.05.011Get rights and content
Under an Elsevier user license
open archive

Key Words

ACC/AHA Clinical Practice Guidelines
angioedema
angiotensin-converting enzyme inhibitors
angiotensin receptor blockers
angiotensin receptor-neprilysin inhibitor
beta blockers
focused update
heart failure
ivabradine
natriuretic peptides

Cited by (0)

Developed in Collaboration With the American College of Chest Physicians and International Society for Heart and Lung Transplantation

This document was approved by the American College of Cardiology Board of Trustees and Executive Committee, the American Heart Association Science Advisory and Coordinating Committee and Executive Committee, and the Heart Failure Society of America Executive Committee in April 2016.

The American College of Cardiology requests that this document be cited as follows: Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol 2016;68:1476–88; http://dx.doi.org/10.1016/j.jacc.2016.05.011.

This article has been copublished in Circulation and the Journal of Cardiac Failure.

Copies: This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org), the American Heart Association (professional.heart.org), and the Heart Failure Society of America (www.hfsa.org). For copies of this document, please contact Elsevier Reprint Department, fax (212) 633-3820 or e-mail [email protected].

Permissions: Multiple copies, modification, alteration, enhancement, and/or distribution of this document are not permitted without the express permission of the American College of Cardiology Foundation. Requests may be completed online via the Elsevier site (http://www.elsevier.com/about/policies/author-agreement/obtaining-permission).

Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information.

ACC/AHA Task Force on Clinical Practice Guidelines Liaison.

ACC/AHA Representative.

§

ACP Representative.

ISHLT Representative.

HFSA Representative.

#

CHEST Representative.

∗∗

ACC/AHA Task Force on Performance Measures Representative.

††

AAFP Representative.